GRAMMY Winning Country Music Trio Lady Antebellum Joins The Leukemia & Lymphoma Society In National Awareness Campaign
Hillary Scott, Charles Kelley, and Dave Haywood Share Personal Stories and Urge Viewers to Donate to Fund Lifesaving Cancer Research
WHITE PLAINS, N.Y., Nov. 6, 2012 /PRNewswire/ -- Seven-time Grammy-award winning country music trio Lady Antebellum join with The Leukemia & Lymphoma Society (LLS) for a new public service campaign to raise awareness and dollars for the lifesaving cancer research funded by the organization.
"Like most people, cancer has touched someone close to each of us recently," said Haywood. "So, it's something that's important to us and we're proud to support The Leukemia & Lymphoma Society's efforts to raise funds for cancer research."
All three band members, Hillary Scott, Charles Kelley, and Dave Haywood, have a strong connection to the LLS mission, each with a family member diagnosed with cancer in the past two years. In the new PSA, Scott talks openly about losing her grandfather to acute myeloid leukemia and his influence on the group. Having been impacted by cancer recently, they share their hope that cancer will be cured in their lifetime. The band urges viewers to donate to LLS to help find cures.
The PSA campaign, directed by filmmaker Jesse Dylan, is being distributed nationally on broadcast and in print.
"Lady Antebellum is an extremely talented and celebrated band and we are so grateful that they are giving their time and energy to support The Leukemia & Lymphoma Society," said John Walter, LLS President and CEO. "LLS is funding the most promising blood cancer research around the world and with Lady Antebellum's help we continue helping patients live longer, better lives."
Critical treatment innovations have originated through blood cancer research, including radiation, chemotherapy, stem cell transplantation, and new-targeted therapies, and significant progress continues to be made. Blood cancer research has been a gateway to finding therapies for many types of cancers. Half of the cancer drugs approved by the FDA in the last decade were first approved to treat patients with blood cancer, and many of these drugs are now being used and/or showing promise as treatments for patients with solid tumors and serious autoimmune diseases.
About Lady Antebellum
Lady Antebellum's current album OWN THE NIGHT debuted at the No. one position on Billboard's Top 200 and has spawned two No. one hits "We Owned The Night" and "Just A Kiss." The trio has sold over 11 million albums across the globe, scored seven GRAMMY Awards and tallied six No. one hits. They recently wrapped their headlining world tour that traveled the US, Canada, Europe and Australia where they were joined by over one million fans in 11 countries on three continents. Lady A is currently nominated for six American Country Awards and one American Music Award in the Country category for "Band, Duo or Group."
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.
Contact: Andrea Greif
SOURCE The Leukemia & Lymphoma Society
More by this Source
The Leukemia & Lymphoma Society Announces Executive Leadership Changes
Feb 11, 2014, 12:30 ET
The Leukemia & Lymphoma Society Announces Recipients of Quest for Cures Grant Program
Jan 23, 2014, 14:21 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.